Answer
Fever (pyrexia, including increased body temperature) was reported in 62.7% of patients in blinatumomab clinical studies involving 1,417 patients with B-cell precursor ALL.
Sources for this answer
- BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusionAmgen Ltd · emc · SmPC §4.8 Undesirable effects · Version 26Document updated
Sources checked